Acima Private Wealth’s AbbVie ABBV Stock Holding History

Acima Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.69M	Sell	6,469 -379	-6%	-$97.2K	0.49%	35
2026 Q2	$1.72M	Hold	6,848	–	–	0.5%	34
2026 Q1	$1.49M	Hold	6,848	–	–	0.47%	37
2025 Q4	$1.56M	Hold	6,848	–	–	0.49%	37
2025 Q3	$1.59M	Buy	6,848 +37	+0.5%	+$7.54K	0.5%	39
2025 Q2	$1.26M	Hold	6,811	–	–	0.43%	42
2025 Q1	$1.43M	Hold	6,811	–	–	0.51%	40
2024 Q4	$1.21M	Hold	6,811	–	–	0.41%	47
2024 Q3	$1.35M	Hold	6,811	–	–	0.45%	46
2024 Q2	$1.17M	Sell	6,811 -220	-3%	-$36.4K	0.43%	45
2024 Q1	$1.28M	Hold	7,031	–	–	0.47%	48
2023 Q4	$1.09M	Sell	7,031 -300	-4%	-$43.7K	0.43%	54
2023 Q3	$1.09M	Sell	7,331 -165	-2%	-$24.2K	0.49%	50
2023 Q2	$1.01M	Hold	7,496	–	–	0.48%	52
2023 Q1	$1.19M	Hold	7,496	–	–	0.59%	46
2022 Q4	$1.21M	Hold	7,496	–	–	0.62%	42
2022 Q3	$1.01M	Hold	7,496	–	–	0.52%	51
2022 Q2	$1.15M	Hold	7,496	–	–	0.57%	47
2022 Q1	$1.22M	Sell	7,496 -17	-0.2%	-$2.47K	0.56%	50
2021 Q4	$1.02M	Hold	7,513	–	–	0.44%	59
2021 Q3	$810K	Hold	7,513	–	–	0.37%	62
2021 Q2	$846K	Hold	7,513	–	–	0.39%	63
2021 Q1	$813K	Hold	7,513	–	–	0.4%	64
2020 Q4	$805K	Buy	7,513 +381	+5%	+$36.6K	0.42%	63
2020 Q3	$625K	Hold	7,132	–	–	0.38%	67
2020 Q2	$700K	Buy	7,132 +19	+0.3%	+$1.67K	0.45%	61
2020 Q1	$542K	Hold	7,113	–	–	0.42%	62
2019 Q4	$630K	Buy	7,113 +220	+3%	+$18.3K	0.44%	60
2019 Q3	$521K	Buy	6,893 +165	+2%	+$11.3K	0.4%	66
2019 Q2	$489K	Hold	6,728	–	–	0.39%	64
2019 Q1	$542K	Hold	6,728	–	–	0.46%	57
2018 Q4	$620K	Buy	+6,728	New	+$592K	0.61%	40

Other funds holding ABBV

HCM

Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

MSV

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Acima Private Wealth's ABBV Position: Q3 2026 in Review

Acima Private Wealth reduced its AbbVie (ABBV) stake by 5.5% in Q3 2026, selling an estimated $97.2K and leaving 6,469 shares worth $1.69M. The position accounts for 0.49% of the portfolio, ranked #35.

Acima Private Wealth first reported a position in ABBV in Q4 2018 and has held it in 32 quarters since. The position peaked at $1.72M in Q2 2026. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Acima Private Wealth held 6,469 shares of AbbVie worth $1.69M as of Q3 2026.
Acima Private Wealth sold 379 AbbVie shares in Q3 2026, an estimated $97.2K.
AbbVie made up 0.49% of Acima Private Wealth's portfolio in Q3 2026, its #35 holding.
Acima Private Wealth first reported a position in AbbVie in Q4 2018 and has held it in 32 quarters since.
Acima Private Wealth's AbbVie position peaked at $1.72M in Q2 2026.
246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Acima Private Wealth's 13F filing for Q3 2026, filed 5 Oct 2026.